$270.57
2.070.77%
Last update: Oct 29, 4:48 PM
Tenet Healthcare Corp
THCNYSE
Tenet Healthcare (THC) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Tenet Healthcare (THC) last issued guidance on October 29, 2026 for fiscal year 2026. The company guided earnings per share in the range of $22.05 - $23.01, compared to a consensus EPS estimate of $21.19. Tenet Healthcare also guided revenue in the range of $22.05B - $22.45B for the period.
Compared to prior guidance, Tenet Healthcare raised its EPS outlook from a previous range of $20.3 - $21.69. On the revenue side, the company maintained its revenue forecast from a prior range of $21.9B - $22.5B.
Tenet Healthcare has issued 24 guidance updates between February 9, 2023 and October 29, 2026. During this period, the company raised its outlook 17 times and lowered it 6 times, providing investors with insight into management's evolving expectations.
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $4.66 | $4.20 | $4.17 | $4.06 |
| Actual | $6.64 | $6.12 | $4.82 | $4.70 |
| Surprise | +42.5% | +45.7% | +15.6% | +15.8% |
| Revenue | ||||
| Estimate | $5.50B | $5.42B | $5.39B | $5.46B |
| Actual | $5.63B | $5.63B | $5.37B | $5.53B |
| Surprise | +2.34% | +3.82% | -0.49% | +1.17% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $5.65 | $5.01 | $5.22 | $4.94 |
| Revenue | ||||
| Consensus | $5.76B | — | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | Oct 29, 2026 | $6.64 | $4.66 | 42.5 % |
| Q2 | Jul 23, 2026 | $6.12 | $4.20 | 45.7 % |
| Q1 | Apr 30, 2026 | $4.82 | $4.17 | 15.6 % |
| Q4 | Feb 11, 2026 | $4.70 | $4.06 | 15.8 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | Oct 29, 2026 | $5.63B | $5.50B | 2.34 % |
| Q2 | Jul 23, 2026 | $5.63B | $5.42B | 3.82 % |
| Q1 | Apr 30, 2026 | $5.37B | $5.39B | -0.49 % |
| Q4 | Feb 11, 2026 | $5.53B | $5.46B | 1.17 % |
